Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 Single- and Multiple-Dose Study of TAK-114 in Healthy Adult Japanese and Caucasian Males
jRCT2080222640Phase 1
- Sponsor
- Takeda
- Start
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of TAK-114 (5 arms), sponsored by Takeda. Primary endpoints: Safety and tolerability of TAK-114 and Pharmacokinetics of TAK-114.
02
Drugs
TAK-114
Beyond the preview
Go deeper on jRCT2080222640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222640.